4.8 Article

A pH-/Enzyme-Responsive Nanoparticle Selectively Targets Endosomal Toll-like Receptors to Potentiate Robust Cancer Vaccination

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Second Near-Infrared Photothermal Semiconducting Polymer Nanoadjuvant for Enhanced Cancer Immunotherapy

Jingchao Li et al.

Summary: This study introduces a novel semiconducting polymer nanoadjuvant for second NIR-II photothermal immunotherapy, which effectively inhibits tumor growth and eliminates metastasis through a combination of photothermal conversion and TLR agonist release.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy

Yaoqi Wang et al.

Summary: The study engineered sequential pH/redox-responsive nanoparticles to activate the immune microenvironment of tumors and lymph nodes, enhancing the antitumor immune response and providing a potential candidate for synergistic cancer chemo-immunotherapy.

NANO LETTERS (2021)

Article Cell Biology

Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models

Yao-Xin Lin et al.

Summary: Clinical evidence suggests that restoration of functional PTEN through mRNA delivery by polymeric nanoparticles can effectively induce immune activation in tumor cells, reversing immunosuppressive tumor microenvironment and enhancing sensitivity to immune checkpoint blockade therapy. In vivo results show that PTEN mRNA nanoparticles promote CD8(+) T cell infiltration, increase proinflammatory cytokine expression, and decrease regulatory T cells and myeloid-derived suppressor cells, resulting in potent antitumor effects and immunological memory in cancer models.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Chemistry, Multidisciplinary

pH/Cathepsin B Hierarchical-Responsive Nanoconjugates for Enhanced Tumor Penetration and Chemo-Immunotherapy

Hongliang Du et al.

ADVANCED FUNCTIONAL MATERIALS (2020)

Article Multidisciplinary Sciences

Cancer immunotherapy comes of age and looks for maturity

Amanda Finck et al.

NATURE COMMUNICATIONS (2020)

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Cryo-shocked cancer cells for targeted drug delivery and vaccination

Tianyuan Ci et al.

SCIENCE ADVANCES (2020)

Review Immunology

Enhancing cancer immunotherapy with nanomedicine

Darrell J. Irvine et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Nanoscience & Nanotechnology

Cancer nanomedicine for combination cancer immunotherapy

Jutaek Nam et al.

NATURE REVIEWS MATERIALS (2019)

Review Biotechnology & Applied Microbiology

Delivery technologies for cancer immunotherapy

Rachel S. Riley et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Multidisciplinary Sciences

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

Caroline S. Jansen et al.

NATURE (2019)

Review Pharmacology & Pharmacy

Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases

Divya Dheer et al.

ADVANCED DRUG DELIVERY REVIEWS (2019)

Review Multidisciplinary Sciences

Personalized vaccines for cancer immunotherapy

Ugur Sahin et al.

SCIENCE (2018)

Article Engineering, Biomedical

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

Christopher B. Rodell et al.

NATURE BIOMEDICAL ENGINEERING (2018)

Review Chemistry, Physical

Biomaterial-assisted targeted modulation of immune cells in cancer treatment

Hua Wang et al.

NATURE MATERIALS (2018)

Article Chemistry, Multidisciplinary

Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses

Lutz Nuhn et al.

ADVANCED MATERIALS (2018)

Article Chemistry, Multidisciplinary

Lymph-Node-Targeted Immune Activation by Engineered Block Copolymer Amphiphiles-TLR7/8 Agonist Conjugates

Simon Van Herck et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)

Article Chemistry, Multidisciplinary

Digitization of Endocytic pH by Hybrid Ultra-pH-Sensitive Nanoprobes at Single-Organelle Resolution

Yiguang Wang et al.

ADVANCED MATERIALS (2017)

Article Nanoscience & Nanotechnology

A STING-activating nanovaccine for cancer immunotherapy

Min Luo et al.

NATURE NANOTECHNOLOGY (2017)

Review Immunology

Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo

Stephan Halle et al.

TRENDS IN IMMUNOLOGY (2017)

Article Chemistry, Multidisciplinary

Efficient Nanovaccine Delivery in Cancer Immunotherapy

Guizhi Zhu et al.

ACS NANO (2017)

Article Multidisciplinary Sciences

pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation

Lutz Nuhn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Immunology

Tissue-resident memory T cells: local specialists in immune defence

Scott N. Mueller et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Biotechnology & Applied Microbiology

In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity

Geoffrey M. Lynn et al.

NATURE BIOTECHNOLOGY (2015)

Article Chemistry, Multidisciplinary

Ultra-pH-Sensitive Nanoprobe Library with Broad pH Tunability and Fluorescence Emissions

Xinpeng Ma et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

Review Immunology

Assembly and localization of Toll-like receptor signalling complexes

Nicholas J. Gay et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Review Biochemistry & Molecular Biology

Key roles of adjuvants in modern vaccines

Steven G. Reed et al.

NATURE MEDICINE (2013)

Review Oncology

Image-guided cancer surgery using near-infrared fluorescence

Alexander L. Vahrmeijer et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2013)

Review Oncology

Trial Watch Experimental Toll-like receptor agonists for cancer therapy

Lorenzo Galluzzi et al.

ONCOIMMUNOLOGY (2012)

Article Oncology

Trial watch FDA-approved Toll-like receptor agonists for cancer therapy

Erika Vacchelli et al.

ONCOIMMUNOLOGY (2012)

Review Immunology

Coordinated regulation of myeloid cells by tumours

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Review Immunology

TLR-based immune adjuvants

Folkert Steinhagen et al.

VACCINE (2011)

Review Immunology

Intracellular Toll-like Receptors

Amanda L. Blasius et al.

IMMUNITY (2010)

Review Immunology

CD28-mediated co-stimulation: A quantitative support for TCR signalling

O Acuto et al.

NATURE REVIEWS IMMUNOLOGY (2003)